[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Exelixis Inc (EXEL)

Exelixis Inc. (EXEL) faces scrutiny over mixed study results and company news, impacting its stock price despite positive trial data and analyst upgrades. Recent insider selling also contributes to the negative price action.

About Exelixis Inc

Exelixis Inc. is a biopharmaceutical company focused on developing cancer treatments.
Exelixis Inc uses the ticker $EXEL for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Exelixis Inc (EXEL) market dominance near a 52-week low at XXXXXXX.
Exelixis Inc (EXEL) trading volume is up XXXXX% from the previous week.
Exelixis Inc (EXEL) social dominance is up XXXXXX% from the previous month.
Exelixis Inc (EXEL) sentiment is up XXXXX% from the previous X months.
Exelixis Inc (EXEL) creators is up XXXXX% from the previous week.
Exelixis Inc (EXEL) mentions is up XXXXX% from the previous week.
Exelixis Inc (EXEL) posts created is up XXXXXX% from the previous week.
Exelixis Inc Sentiment hit a 52-Week high of XXX for the day

Price: $XXXXX

Price 24-Hour Time-Series Raw Data
The stock price is down, primarily driven by mixed study results and negative company news, outweighing positive trial data and analyst upgrades. Recent insider selling also contributes to the negative price action.

24-Hour: XXXX% 7-Day: -XXXX% 30-Day: -XXXX%

1-Year High: $XXXXX on 2025-05-15
1-Year Low: $XXXXX on 2025-01-25

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Exelixis Inc (EXEL) is currently AltRank #972 based on combined combined social and market metrics Daily Average: XXX
X Week: XXX -XXX
X Month: XXX -XXX
X Months: XXX +363
X Year: XXX -XXX
1-Year High: XXXXX on 2025-05-06
1-Year Low: XX on 2025-05-15

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -X
X Month: XX -XX
X Months: XX -X
X Year: XX -XX
1-Year High: XX on 2024-12-15
1-Year Low: XX on 2025-05-07

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXXX -XXXX%
X Month: XXXXXXX +116%
X Months: XXXXXXXXX -XXXX%
X Year: XXXXXXXXX +284%
1-Year High: XXXXXXX on 2025-06-05
1-Year Low: XXX on 2025-02-01

Engagements by network (24h): Reddit: XX TikTok: X X: XXXXX YouTube: XXXXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX +18%
X Month: XXX -XXXX%
X Months: XXXXX +112%
X Year: XXXXX +169%
1-Year High: XXX on 2025-06-24
1-Year Low: XX on 2025-02-02

Mentions by network (24h): Reddit: XX TikTok: X X: XXX YouTube: XX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Exelixis Inc (EXEL) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XXX +40%
X Month: XXX +19%
X Months: XXXXX +149%
X Year: XXXXX +154%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-09-15

The most influential creators that mention Exelixis Inc in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@Tickeron	X	XXXXXX	XX	XXX
@BioValues	X	XXXXX	X	XXX
@BuyTheUgly	X	XX	X	XXX
@TheOptionsBull2	X	XXX	X	XX
@seedytx19	X	XXXXX	X	XX
@ParadiseTraderr	X	XXX	X	XX
@TumorBoardTues	X	XXXXX	X	XX
@FNicolasFloyd	X	XXX	X	XX
@NiloksF3529	X	XX	X	X
@NightOwlBiotech	XX	XXXXX	X	X

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XXX% +25%
X Month: XXX% +12%
X Months: XXX% +35%
X Year: XXX% +6%
1-Year High: XXX% on 2025-12-12
1-Year Low: XX% on 2025-02-10

Most Supportive Themes:

Positive Trial Results: (50%) Positive trial data from a colorectal cancer study has been reported.
Analyst Upgrades: (30%) Several analysts have upgraded Exelixis Inc. (EXEL), indicating positive sentiment from financial experts.

Most Critical Themes:

Mixed Study Results: (60%) The colorectal cancer study yielded mixed results, leading to a decline in Exelixis Inc. (EXEL) shares.
Layoffs and Site Closure: (40%) Negative news regarding layoffs and a site closure at Exelixis Inc. is contributing to the stock's downturn.

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXXX% +0.0013%
X Month: XXXXX% +0.021%
X Months: XXXXX% +0.011%
X Year: XXXXX% +0.011%
1-Year High: XXXXX% on 2025-06-24
1-Year Low: XXXXXX% on 2025-09-27

Market Dominance: XXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-10
1-Year Low: XXXXX% on 2025-12-11

Market Cap: $XXXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXX -$6.50%
X Month: $XXXXXXXXXXXXXX -$3.40%
X Months: $XXXXXXXXXXXXXX -$1.90%
X Year: $XXXXXXXXXXXXXX +$10%
1-Year High: $XXXXXXXXXXXXXX on 2025-05-15
1-Year Low: $XXXXXXXXXXXXX on 2025-02-12